As of Jul 31
| +0.03 / +0.13%|
The 10 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 37.00, with a high estimate of 45.00 and a low estimate of 32.00. The median estimate represents a +57.11% increase from the last price of 23.55.
The current consensus among 10 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.